Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Cardinal Health Inc is a medical distribution business based in the US. Cardinal Health shares (CAH) are listed on the NYSE and all prices are listed in US Dollars. Cardinal Health employs 46,354 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $50.56 |
|---|---|
| 52-week range | $45.42 - $60.77 |
| 50-day moving average | $49.90 |
| 200-day moving average | $53.78 |
| Wall St. target price | $56.46 |
| PE ratio | 13.7042 |
| Dividend yield | $1.953 (3.7%) |
| Earnings per share (TTM) | $3.87 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $50.56 from 2022-01-21
| 1 week (2022-01-13) | -3.22% |
|---|---|
| 1 month (2021-12-23) | -0.37% |
| 3 months (2021-10-20) | N/A |
| 6 months (2021-07-23) | -14.59% |
| 1 year (2021-01-22) | -8.72% |
|---|---|
| 2 years (2020-01-23) | -7.85% |
| 3 years (2019-01-23) | 3.46% |
| 5 years (2017-01-23) | 74.72 |
Valuing Cardinal Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cardinal Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cardinal Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Cardinal Health shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Cardinal Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.501. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cardinal Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cardinal Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.7 billion.
The EBITDA is a measure of a Cardinal Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $167.4 billion |
|---|---|
| Operating margin TTM | 1.18% |
| Gross profit TTM | $7 billion |
| Return on assets TTM | 2.92% |
| Return on equity TTM | 80.61% |
| Profit margin | 0.68% |
| Book value | $4.91 |
| Market capitalisation | $15 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Cardinal Health.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 12.66
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Cardinal Health's overall score of 12.66 (as at 12/31/2018) is excellent – landing it in it in the 6th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Cardinal Health is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 0.25/100
Social score: 5.84/100
Governance score: 1.08/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Cardinal Health scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Cardinal Health hasn't always managed to keep its nose clean.
Cardinal Health Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 12.66 |
|---|---|
| Total ESG percentile | 6.34 |
| Environmental score | 0.25 |
| Social score | 5.84 |
| Governance score | 1.08 |
| Level of controversy | 3 |
Dividend payout ratio: 36.74% of net profits
Recently Cardinal Health has paid out, on average, around 36.74% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.7% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cardinal Health shareholders could enjoy a 3.7% return on their shares, in the form of dividend payments. In Cardinal Health's case, that would currently equate to about $1.953 per share.
While Cardinal Health's payout ratio might seem fairly standard, it's worth remembering that Cardinal Health may be investing much of the rest of its net profits in future growth.
Cardinal Health's most recent dividend payout was on 14 January 2022. The latest dividend was paid out to all shareholders who bought their shares by 30 December 2021 (the "ex-dividend date").
Cardinal Health's shares were split on a 3:2 basis on 22 April 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Cardinal Health shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Cardinal Health shares which in turn could have impacted Cardinal Health's share price.
Over the last 12 months, Cardinal Health's shares have ranged in value from as little as $45.4187 up to $60.7683. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cardinal Health's is 0.9975. This would suggest that Cardinal Health's shares are less volatile than average (for this exchange).
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.